USUSDSep 28, 23:26
Roivant Sciences Ltd ROIV
About TRY 1,812.03 · converted at USD/TRY 49.0003, September 29, 2026, 14:34
- Volume
- 7M
- Day range
- 35.28 – 37.25
- Previous close
- 35.80
- Market cap
- USD 26.7B
Key Data
- Market cap
- USD 26.7B
- EPS
- USD −0.47
- 52 weeks
- 14.7041.81
- Day range
- 35.2837.25
- 1-year return
- 151.56%
- Previous close
- 35.80
- Open
- 35.65
- Volume
- 7M
- Avg. volume (200d)
- 6.7M
- Sector
- Healthcare
- Industry
- Biotechnology
Technical Signals
Technical signals
Only our Plus members can access this area.
AI Models
AI models
Only our Plus members can access this area.
About Roivant Sciences Ltd
Roivant Sciences Ltd (ROIV) last traded at 36.98 USD on the US stock market, a daily move of 3.30%. Converted at the USD/TRY rate of 49.0003 as of September 29, 2026, 14:34, this price equals about TRY 1,812.03; the conversion is for information only and the rate a broker applies may differ. Market capitalization is 26.7B USD, earnings per share −0.47 USD, the price-to-earnings ratio — and the dividend yield —. The company operates in the Healthcare sector, within the Biotechnology industry. The 52-week range is 14.70 – 41.81 USD; the one-year return is 151.56%.
Frequently Asked Questions
What is the ROIV stock price today?
Roivant Sciences Ltd (ROIV) last traded at 36.98 USD, a daily change of 3.30%. Prices are delayed by at least 15 minutes.
How much is Roivant Sciences Ltd (ROIV) stock in Turkish lira?
The last price of Roivant Sciences Ltd (ROIV) is USD 36.98. Converted at the USD/TRY rate of 49.0003 as of September 29, 2026, 14:34, that is about TRY 1,812.03. The conversion is for information only; trades use the exchange rate and fees your broker applies.
How can I buy US stocks from Türkiye?
US stocks such as Roivant Sciences Ltd (ROIV) can be bought through Turkish brokerage firms (aracı kurumlar) that offer access to foreign markets. You open an account enabled for foreign equity trading; because US stocks trade in dollars, the account and trades are in USD, so lira savings are converted to dollars first. The regular session on the NYSE and Nasdaq runs from 09:30 to 16:00 New York time, which is 16:30–23:00 Türkiye time while US daylight saving time is in effect and 17:30–00:00 otherwise. Taxation is subject to Turkish tax law; check the Revenue Administration (GİB) for current rules.
What are the P/E ratio and market cap of ROIV?
ROIV trades at a price-to-earnings ratio of —, with earnings per share of −0.47 USD and a market capitalization of 26.7B USD. Ratios use the latest reported results and the current price.
What is the 52-week range of ROIV?
Over the past 52 weeks ROIV traded between 14.70 and 41.81 USD; the one-year return is 151.56%.
Does ROIV pay a dividend?
The current dividend yield of ROIV is —. Dividend yield is the annual cash dividend divided by the share price; the company may change its policy.
What sector is Roivant Sciences Ltd in?
Roivant Sciences Ltd (ROIV) is listed on the US stock market; its sector is Healthcare and its industry is Biotechnology.
Where does the data on this page come from and how fresh is it?
Prices, volume and fundamentals come from licensed data providers; prices are delayed by at least 15 minutes and fundamentals refresh daily. AI forecasts are generated by Yatırımcı.AI models and are not investment advice.